Alpha 2.0
Login Register
» Authors » P Storti

P Storti

Explore the profile of P Storti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 314
Followers 0
Related Specialties
Oncology
Hematology
General Medicine
Top 10 Co-Authors
N Giuliani
M Bolzoni
A Neri
L Agnelli
M Lazzaretti
S Colla
G DOnofrio
K Todoerti
E Martella
S Bonomini
Published In
Leukemia
Hospital (Rio J)
Affiliations
Soon will be listed here.
Recent Articles
1.
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo
Storti P, Marchica V, Airoldi I, DOnofrio G, Fiorini E, Ferri V, et al.
Leukemia . 2016 Jun; 30(12):2351-2363. PMID: 27311934
Galectin-1 (Gal-1) is involved in tumoral angiogenesis, hypoxia and metastases. Actually the Gal-1 expression profile in multiple myeloma (MM) patients and its pathophysiological role in MM-induced angiogenesis and tumoral growth...
2.
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
Silbermann R, Bolzoni M, Storti P, Guasco D, Bonomini S, Zhou D, et al.
Leukemia . 2013 Dec; 28(4):951-4. PMID: 24369304
No abstract available.
3.
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
Storti P, Bolzoni M, DOnofrio G, Airoldi I, Guasco D, Toscani D, et al.
Leukemia . 2013 Jan; 27(8):1697-706. PMID: 23344526
Hypoxia-inducible transcription factor-1 (HIF-1α) is overexpressed in multiple myeloma (MM) cells within the hypoxic microenvironment. Herein, we explored the effect of persistent HIF-1α inhibition by a lentivirus short hairpin RNA...
4.
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells
Bolzoni M, DOnofrio G, Storti P, Guasco D, Toscani D, Lazzaretti M, et al.
Leukemia . 2012 Jul; 27(2):451-63. PMID: 22781592
Multiple myeloma (MM) is characterized by the impaired osteogenic differentiation of human mesenchymal stromal cells (hMSCs). Canonical Wnt signaling is critical for the regulation of bone formation, however, recent evidence...
5.
Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
Giuliani N, Ferretti M, Bolzoni M, Storti P, Lazzaretti M, Palma B, et al.
Leukemia . 2012 Feb; 26(6):1391-401. PMID: 22289923
The involvement of osteocytes in multiple myeloma (MM)-induced osteoclast (OCL) formation and bone lesions is still unknown. Osteocytes regulate bone remodelling at least partially, as a result of their cell...
6.
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients
Storti P, DOnofrio G, Colla S, Airoldi I, Bolzoni M, Agnelli L, et al.
Leukemia . 2010 Dec; 25(3):527-37. PMID: 21183939
The deregulation of the homeobox genes as homeoboxB (HOXB)-7 has been previously associated to tumor progression and angiogenesis; here we investigated the potential role of HOXB7 in the pro-angiogenic properties...
7.
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells
Colla S, Storti P, DOnofrio G, Todoerti K, Bolzoni M, Lazzaretti M, et al.
Leukemia . 2010 Sep; 24(11):1967-70. PMID: 20811474
No abstract available.
8.
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients
Giuliani N, Lisignoli G, Novara F, Storti P, Zaffaroni N, Villa R, et al.
Leukemia . 2010 May; 24(7):1368-70. PMID: 20485369
No abstract available.
9.
[The use of meprobamate in goiter with hyperthyroidism]
Guglielmetti R, Simao R, Storti P, Storti C
Hospital (Rio J) . 1959 Aug; 56:339-43. PMID: 13830108
No abstract available.